These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 10977478)

  • 1. The economic burden of congestive heart failure in a managed care population.
    Xuan J; Duong PT; Russo PA; Lacey MJ; Wong B
    Am J Manag Care; 2000 Jun; 6(6):693-700. PubMed ID: 10977478
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying opportunities to address the congestive heart failure burden: the Improving Cardiovascular Outcomes in Nova Scotia (ICONS) study.
    Howlett JG; Johnstone DE; Sketris I; O'Reilly M; Horne GS; Cox JL;
    Can J Cardiol; 2003 Mar; 19(4):439-44. PubMed ID: 12704493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of chronic heart failure in a managed care setting. Baseline results from the Achieving Cardiac Excellence Project.
    Schmedtje JF; Evans GW; Byerly W; King M; Goonan K; Blastock-Glenn C; Croft JB; Goff DC
    N C Med J; 2003; 64(1):4-10. PubMed ID: 12774552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
    Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
    Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug copayment and adherence in chronic heart failure: effect on cost and outcomes.
    Cole JA; Norman H; Weatherby LB; Walker AM
    Pharmacotherapy; 2006 Aug; 26(8):1157-64. PubMed ID: 16863491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilization of, and adherence to, drug therapy among medicaid beneficiaries with congestive heart failure.
    Bagchi AD; Esposito D; Kim M; Verdier J; Bencio D
    Clin Ther; 2007 Aug; 29(8):1771-83. PubMed ID: 17919558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Economic implications of treatment guidelines for congestive heart failure.
    Shibata MC; Nilsson C; Hervas-Malo M; Jacobs P; Tsuyuki RT
    Can J Cardiol; 2005 Dec; 21(14):1301-6. PubMed ID: 16341301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Resource utilisation, charges and mortality following hospital inpatient admission for congestive heart failure among the elderly in the US.
    Bharmal M; Gemmen E; Zyczynski T; Linnstaedt A; Kenny D; Marelli C
    J Med Econ; 2008; 11(3):397-414. PubMed ID: 19450095
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological treatment of congestive heart failure in Canada: a description of care in five provinces.
    Cox JL; Ramer SA; Lee DS; Humphries K; Pilote L; Svenson L; Tu JV;
    Can J Cardiol; 2005 Mar; 21(4):337-43. PubMed ID: 15838560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost of heart failure among hypertensive users of nonspecific NSAIDs and COX-2-specific inhibitors.
    Zhao SZ; Burke TA; Whelton A; von Allmen H; Henderson SC
    Am J Manag Care; 2002 Oct; 8(15 Suppl):S414-27. PubMed ID: 12416791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Medical treatment of heart failure: an analysis of actual treatment practices in outpatients in Switzerland. The Swiss "IMPROVEMENT of HF" Group].
    Muntwyler J; Follath F
    Schweiz Med Wochenschr; 2000 Aug; 130(34):1192-8. PubMed ID: 11013922
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the rise: The current and projected future burden of congestive heart failure hospitalization in Canada.
    Johansen H; Strauss B; Arnold JM; Moe G; Liu P
    Can J Cardiol; 2003 Mar; 19(4):430-5. PubMed ID: 12704491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care and medication costs and use among older adults with heart failure.
    Stroupe KT; Teal EY; Weiner M; Gradus-Pizlo I; Brater DC; Murray MD
    Am J Med; 2004 Apr; 116(7):443-50. PubMed ID: 15047033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic burden of rhinitis in managed care: a retrospective claims data analysis.
    Dalal AA; Stanford R; Henry H; Borah B
    Ann Allergy Asthma Immunol; 2008 Jul; 101(1):23-9. PubMed ID: 18681080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Heart failure: critical patients].
    Fabbri G; Gorini M; Maggioni AP; Oliva F;
    G Ital Cardiol (Rome); 2007 Sep; 8(9):568-73. PubMed ID: 17972426
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment patterns for heart failure in a primary care environment.
    Simko RJ; Stanek EJ
    Am J Manag Care; 1997 Nov; 3(11):1669-76. PubMed ID: 10178465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mortality risk and patterns of practice in 4606 acute care patients with congestive heart failure. The relative importance of age, sex, and medical therapy. Clinical Quality Improvement Network Investigators.
    Arch Intern Med; 1996 Aug 12-26; 156(15):1669-73. PubMed ID: 8694665
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare utilization and costs of patients with rosacea in an insured population.
    Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
    J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of elderly patients with congestive heart failure--design of the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME-CHF).
    Brunner-La Rocca HP; Buser PT; Schindler R; Bernheim A; Rickenbacher P; Pfisterer M;
    Am Heart J; 2006 May; 151(5):949-55. PubMed ID: 16644310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incremental effects of concurrent pharmacotherapeutic regimens for heart failure on hospitalizations and costs.
    Skrepnek GH; Abarca J; Malone DC; Armstrong EP; Shirazi FM; Woosley RL
    Ann Pharmacother; 2005 Nov; 39(11):1785-91. PubMed ID: 16219900
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.